<?xml version="1.0" encoding="UTF-8"?>
<mods xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns="http://www.loc.gov/mods/v3" version="3.1" xsi:schemaLocation="http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-1.xsd">
  <titleInfo>
    <title>Pantothenate kinase-associated neurodegeneration (PKAN)–a rare clinicalentity</title>
  </titleInfo>
  <name type="personal">
    <namePart>Appas Sahaa</namePart>
    <role>
      <roleTerm authority="marcrelator" type="text">creator</roleTerm>
    </role>
  </name>
  <name type="personal">
    <namePart>Srushti Shabnamband</namePart>
  </name>
  <name type="personal">
    <namePart>Swapna, N</namePart>
  </name>
  <typeOfResource>text</typeOfResource>
  <originInfo>
    <place>
      <placeTerm type="code" authority="marccountry">xx</placeTerm>
    </place>
    <publisher> Informa UK Limited</publisher>
    <dateIssued>2016</dateIssued>
    <dateIssued encoding="marc">9999</dateIssued>
    <issuance>monographic</issuance>
  </originInfo>
  <language>
    <languageTerm authority="iso639-2b" type="code">und</languageTerm>
  </language>
  <physicalDescription>
    <form authority="marcform">print</form>
    <extent>90–97</extent>
  </physicalDescription>
  <abstract>Pantothenate kinase-associated neurodegeneration (PKAN) is an autosomal recessive disordercaused by the absence or deficiency of PANK 2 gene located on the chromosome 20p13-p12.3.This is a motor disorder of extrapyramidal type with dystonia, rigidity, involuntary movements(choreoathetosis or tremor) and other pyramidal signs. We present the case of a patient, 13-year-old boy with PKAN who reported to our institute. The assessment revealed dystonia, dys-phagia, oro-motor weakness, increased tone in facial and cervical region, dysarthria, poor speechintelligibility and mild intellectual deficit. After a detailed assessment, the patient was recom-mended speech therapy, swallowing management and occupational therapy. He attended twosessions of EMG biofeedback therapy for the reduction of tone and 26 sessions of speech ther-apy. The EMG biofeedback therapy, relaxation exercises and massaging were helpful in reducingthe tonicity of the muscles and isotonic and isomeric exercises carried out during speech therapyimproved the oro-motor mobility and strength. He was also able to phonate the vowels withlesser effort. There was an improvement in the oral preparatory and oral transport phase of swal-low with no aspiration reported. Thus, it can be concluded that speech and swallowing manage-ment on a long-term basis is essential for patients with PKAN.</abstract>
  <subject>
    <topic>Hallervorden–Spatz disease;pantothenate kinase-associated neurodegenera-tion; dysarthria; dysphagia</topic>
  </subject>
  <relatedItem type="host">
    <name>
      <namePart>ACTA OTO-LARYNGOLOGICA CASE REPORTS</namePart>
    </name>
  </relatedItem>
  <identifier type="issn">2377-2484</identifier>
  <identifier type="uri">https://doi.org/10.1080/23772484.2016.1247649</identifier>
  <location>
    <url>https://doi.org/10.1080/23772484.2016.1247649</url>
  </location>
  <recordInfo>
    <recordCreationDate encoding="marc">210629</recordCreationDate>
  </recordInfo>
</mods>
